Intuitive Surgical, Inc. (NASDAQ:ISRG) Given Average Rating of "Moderate Buy" by Analysts

Intuitive Surgical, Inc. (NASDAQ:ISRG - Get Free Report) has been assigned an average rating of "Moderate Buy" from the twenty analysts that are covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, four have issued a hold recommendation and fifteen have issued a buy recommendation on the company. The average 1 year price objective among brokers that have issued ratings on the stock in the last year is $592.86.

Several equities research analysts have recently weighed in on ISRG shares. BTIG Research set a $566.00 target price on shares of Intuitive Surgical and gave the stock a "buy" rating in a report on Monday, July 14th. Citigroup reiterated a "buy" rating and set a $650.00 target price (up from $590.00) on shares of Intuitive Surgical in a research report on Thursday, May 22nd. Evercore ISI upped their target price on shares of Intuitive Surgical from $470.00 to $550.00 and gave the stock an "in-line" rating in a research report on Tuesday, July 8th. Barclays reduced their target price on shares of Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating on the stock in a research note on Thursday, April 24th. Finally, Erste Group Bank raised shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a research note on Thursday, June 5th.

Insiders Place Their Bets

In other Intuitive Surgical news, SVP Mark Brosius sold 216 shares of the business's stock in a transaction that occurred on Friday, June 6th. The stock was sold at an average price of $563.11, for a total transaction of $121,631.76. Following the completion of the sale, the senior vice president directly owned 907 shares in the company, valued at approximately $510,740.77. The trade was a 19.23% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Jami K. Nachtsheim sold 2,400 shares of the business's stock in a transaction that occurred on Thursday, May 1st. The stock was sold at an average price of $520.00, for a total value of $1,248,000.00. Following the transaction, the director owned 6,371 shares in the company, valued at approximately $3,312,920. This represents a 27.36% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 4,998 shares of company stock worth $2,611,577 over the last quarter. Company insiders own 0.70% of the company's stock.

Institutional Trading of Intuitive Surgical

Several hedge funds have recently modified their holdings of ISRG. Chilton Capital Management LLC grew its holdings in shares of Intuitive Surgical by 614.3% during the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider's stock worth $25,000 after buying an additional 43 shares during the last quarter. Parvin Asset Management LLC purchased a new stake in Intuitive Surgical in the 4th quarter valued at approximately $26,000. Global Financial Private Client LLC boosted its holdings in Intuitive Surgical by 253.3% in the 1st quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider's stock valued at $26,000 after purchasing an additional 38 shares in the last quarter. Elite Financial Inc. purchased a new stake in Intuitive Surgical in the 1st quarter valued at approximately $26,000. Finally, Hurley Capital LLC purchased a new stake in Intuitive Surgical in the 4th quarter valued at approximately $28,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Stock Performance

NASDAQ ISRG traded down $2.50 during mid-day trading on Monday, reaching $516.12. 1,638,346 shares of the stock were exchanged, compared to its average volume of 1,666,208. The stock has a market capitalization of $184.99 billion, a PE ratio of 81.42, a PEG ratio of 5.50 and a beta of 1.64. Intuitive Surgical has a 1-year low of $425.00 and a 1-year high of $616.00. The business's fifty day simple moving average is $535.90 and its 200 day simple moving average is $536.29.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, beating the consensus estimate of $1.71 by $0.10. The business had revenue of $2.25 billion during the quarter, compared to analyst estimates of $2.19 billion. Intuitive Surgical had a net margin of 28.41% and a return on equity of 14.43%. During the same period in the previous year, the business posted $1.50 EPS. On average, analysts anticipate that Intuitive Surgical will post 6.43 EPS for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.